Abstract
Aims: For patients with a craniofacial deformity due to tumor surgery a facial prosthesis is still the best option. The clinical outcome of implant-retained prostheses in the orbital and auricular region and patient satisfaction was studied. Method: Twenty-six patients were treated with implant-retained prostheses (Branemark implants, n -75). Thirteen patients (n = 35 implants) received the implants during ablative tumor surgery. Eight of them (n = 24 implants) were irradiated (> 60 Gy) post-surgery. Thirteen patients (n = 40 implants) received the implants 1-441 years after tumor surgery. Four of them (n = 17 implants) were irradiated (33-66 Gy) prior to implant placement. Various clinical outcome parameters were assessed. Patient satisfaction was evaluated using standardized questionnaires. Results: The overall implant survival rate (mean follow up 44.7±5.1 months) was 93.4%. No implants were lost in non-irradiated patients (implant survival 100%), while five implants were lost in the irradiated group (87.8%). The peri-implant tissues were mostly healthy and no cases of osteoradionecrosis occurred. When compared with patients treated with adhesive retained prostheses, satisfaction was higher in patients treated with implant-retained facial prostheses (t = 6.88, P < 0.001). Conclusion: Implant-retained facial prostheses are better tolerated than adhesive retained prostheses. Furthermore, post-surgery radiotherapy is not a contraindication to use osseointegrated implants, although it reduces implant survival rate.
| Original language | English |
|---|---|
| Pages (from-to) | S39-S40 |
| Journal | Oral Oncology |
| Volume | 37 |
| Issue number | SUPPL. 1 |
| Publication status | Published - 2001 |